Clinical Trial Update: Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC [Phase 2]

View source ↗

Summary

Phase 2 trial investigating perioperative chemotherapy combined with tislelizumab and trastuzumab for stomach cancer/early gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Stomach Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)
• Trastuzumab (trastuzumab)
• perioperative chemotherapy

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Stomach Cancer | Phase 2 | Status: UNKNOWN